Literature DB >> 7134858

Bypass revision in unsatisfactory weight loss after jejunoileal bypass for morbid obesity.

J Miskowiak, B Andersen.   

Abstract

Sixteen patients with unsatisfactory weight loss after end-to-side jejunoileal bypass were treated with either simple resection of the elongated segment of the shunt (10 patients) or resection combined with conversion to an end-to-end anastomosis (Scott) (6 patients). This led to an additional median weight loss of 13.5 kg (range, 3-25 kg) after 1 year. Scott's procedure yielded the greatest weight loss, but the price was bypass enteritis, arthritis, or electrolyte disturbances in all but one patient. Two of these patients required conversion to gastroplasty. After simple resection of the shunt less than half of the patients required electrolyte supplementation. Most of these patients, however, had unsatisfactory weight loss, which necessitated further surgery in five patients. Only 6 of the 16 patients had good results. In consequence, we have for the past 2 years used conversion to gastroplasty in patients with unsatisfactory weight loss after jejunoileal bypass.

Entities:  

Mesh:

Year:  1982        PMID: 7134858     DOI: 10.3109/00365528209182060

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique.

Authors:  Andrés Sánchez-Pernaute; Miguel Angel Rubio Herrera; Elia Pérez-Aguirre; Juan Carlos García Pérez; Lucio Cabrerizo; Luis Díez Valladares; Cristina Fernández; Pablo Talavera; Antonio Torres
Journal:  Obes Surg       Date:  2007-11-27       Impact factor: 4.129

Review 2.  Management and Complications of Short Bowel Syndrome: an Updated Review.

Authors:  Robert E Carroll; Enrico Benedetti; Joseph P Schowalter; Alan L Buchman
Journal:  Curr Gastroenterol Rep       Date:  2016-07

Review 3.  An epilogue to jejunoileal bypass.

Authors:  R M Baddeley
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.